Prostaglandin E2 strongly inhibits human osteoclast formation

Endocrinology

Volumn 146, Issue 12, 2005, Pages 5204-5214

  Take, Ikuko ^a   Kobayashi, Yasuhiro ^a   Yamamoto, Yohei ^b   Tsuboi, Hideki ^c   Ochi, Takahiro ^d   Uematsu, Setsuko ^a   Okafuji, Norimasa ^a   Kurihara, Saburo ^a   Udagawa, Nobuyuki ^a   Takahashi, Naoyuki ^a  

^a MATSUMOTO DENTAL UNIVERSITY   (Japan)

^b AICHI GAKUIN UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d SAGAMIHARA NATIONAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; G PROTEIN COUPLED RECEPTOR; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE; PROSTAGLANDIN E1; PROSTAGLANDIN E2; CARRIER PROTEIN; CD14 ANTIGEN; MEMBRANE PROTEIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N-(2-CYCLOHEXYLOXY-4-NITROPHENYL)METHANESULFONAMIDE; NITROBENZENE DERIVATIVE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN SYNTHASE INHIBITOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SULFONAMIDE; TNFRSF11A PROTEIN, HUMAN; TNFRSF11A PROTEIN, MOUSE; TNFSF11 PROTEIN, HUMAN; TNFSF11 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NONHUMAN; OSTEOCLAST; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ADULT; ANIMAL; BONE MARROW CELL; COCULTURE; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; FEMALE; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; MONOCYTE;

ADULT; ANIMALS; ANTIGENS, CD14; BONE MARROW CELLS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; FEMALE; HUMANS; MACROPHAGES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MIDDLE AGED; MONOCYTES; NITROBENZENES; OSTEOCLASTS; PARATHYROID HORMONE; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, PROSTAGLANDIN E; SULFONAMIDES;

EID: 27844592641     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-0451     Document Type: Article

References (40)

1. Baron R, Neff L, Tran Van P, Nefussi JR, Vignery A 1986 Kinetic and cytochemical identification of osteoclast precursors and their differentiation into multinucleated osteoclasts. Am J Pathol 122:363-378
2. Chambers TJ 2000 Regulation of the differentiation and function of osteoclasts. J Pathol 192:4-13
3. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ 1999 Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20:345-357
4. Teitelbaum SL, Ross FP 2003 Genetic regulation of osteoclast development and function. Nat Rev Genet 4:638-649
5. Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM, Martin TJ, Suda T 1988 Osteoblastic cells are involved in osteoclast formation. Endocrinology 123:2600-2602
6. Boyle WJ, Simonet WS, Lacey DL 2003 Osteoclast differentiation and activation. Nature 423:337-342
7. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclast genesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602
8. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176
9. Matsuzaki K, Kitayama K, Takahashi Y, Nakamura I, Udagawa N, Tsurukai T, Nishinakamura R, Toyama Y, Yabe Y, Hori M, Takahashi N, Suda T 1999 Human osteoclast-like cell are formed from peripheral blood mononuclear cells in a coculture with SaOS-2 cells transfected with the parathyroid hormone (PTH)/PTH-related protein receptor gene. Endocrinology 140:925-932
10. Pilbeam CC, Harrison JR, Raisz LG 2002 Prostaglandins and bone metabolism. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principle of bone biology. 2nd ed. Vol 2. San Diego: Academic Press; 979-994
11. Narumiya S, Sugimoto Y, Ushikubi F 1999 Prostanoid receptors: structures, properties, and functions. Physiol Rev 79:1193-1226
12. Narumiya S, FitzGerald GA 2001 Genetic and pharmacological analysis of prostanoid receptor function. J Clin Invest 108:25-30
13. Watabe A, Sugimoto Y, Honda A, Irie A, Namba T, Negishi M, Ito S, Narumiya S, Ichikawa A 1993 Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor. J Biol Chem 268:20175-20178
14. Katsuyama M, Nishigaki N, Sugimoto Y, Morimoto K, Negishi M, Narumiya S, Ichikawa A 1995 The mouse prostaglandin E receptor EP2 subtype: cloning, expression, and northern blot analysis. FEBS Lett 372:151-156
15. Nishigaki N, Negishi M, Honda A, Sugimoto Y, Namba T, Narumiya S, Ichikawa A 1995 Identification of prostaglandin E receptor EP2 cloned from mastocytoma cells EP4 subtype. FEBS Lett 364:339-341
16. Sugimoto Y, Namba T, Honda A, Hayashi Y, Negishi M, Ichikawa A, Narumiya S 1992 Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype. J Biol Chem 267:6463-6466
17. Suzawa T, Miyaura C, Inada M, Maruyama T, Sugimoto Y, Ushikubi F, Ichikawa A, Narumiya S, Suda T 2000 The role of prostaglandin E receptor subtypes (EP1, EP2, EP3 and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology 141:1554-1559
18. Li X, Okada Y, Pilbeam CC, Lorenzo JA, Kennedy CR, Breyer RM, Raisz LG 2000 Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro. Endocrinology 141:2054-2061
19. Tomita M, Li X, Okada Y, Woodiel FN, Young RN, Pilbeam CC, Raisz LG 2002 Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro. Bone 30:159-163
20. Tintut Y, Parhami F, Tsingotjidou A, Tetradis S, Territo M, Demer LL 2002 8-Isoprostaglandin E2 enhances receptor-activated NFκB ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway. J Biol Chem 277:14221-14226
21. 2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors: synergistic activation of differentiation, cell spreading, and fusion. Endocrinology 140:1927-1935
22. 2 enhances osteoclastic differentiation of precursor cells through protein kinase A-dependent phosphorylation of TAK1. J Biol Chem 280:11395-11403
23. Ono K, Akatsu T, Murakami T, Nishikawa M, Yamamoto M, Kugai N, Motoyoshi K, Nagata N 1998 Important role of EP4, a subtype of prostaglandin (PG) E receptor, in osteoclast-like cell formation from mouse bone marrow cells induced by PGE2. J Endocrinol 158:1-5
24. 2 act directly on circulating human osteoclast precursors. Biochem Biophys Res Commun 264:590-595
25. 2, interleukin 1α, and tumor necrosis factor-α increase human osteoclast formation and bone resorption in vitro. Endocrinology 139:3157-3164
26. Takano H, Tomita T, Toyosaki-Maeda T, Maeda-Tanimura M, Tsuboi H, Takeuchi E, Kaneko M, Shi K, Takahi K, Myoui A, Yoshikawa H, Takahashi T, Suzuki R, Ochi T 2004 Comparison of the activities of multinucleated bone-resorbing giant cells derived from CD14-positive cells in the synovial fluids of rheumatoid arthritis and osteoarthritis patients. Rheumatology 43:435-441
27. Takahashi N, Udagawa N, Tanaka S, Suda T 2003 Generating murine osteoclasts from bone marrow. Methods Mol Med 80:129-144
28. Kurihara N, Civin C, Roodman GD 1991 Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype. J Bone Miner Res 6:257-261
29. 2 on osteoclast formation in spleen cell cultures: role of the EP2 receptor. J Bone Miner Res 20:23-29
30. Raisz LG, Vanderhoek JY, Simmons HA, Kream BE, Nicolaou KC 1979 Prostaglandin synthesis by fetal rat bone in vitro: evidence for a role of prostacyclin. Prostaglandins 17:905-914
31. Kanatani M, Sugimoto T, Fukase M, Chihara K 1994 Role of interleukin-6 and prostaglandins in the effect of monocyte-conditioned medium on osteoclast formation. Am J Physiol 267:E868-E876
32. 2 receptors EP2 and EP4 are down-regulated during differentiation of mouse osteoclasts from their precursors. J Biol Chem 280:24035-24042
33. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T, Hidaka H 1990 Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(ρ-bromocinnamylamino)ethyl]-5- isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 265:5267-5272
34. Itonaga I, Sabokbar A, Sun SG, Kudo O, Danks L, Ferguson D, Fujikawa Y, Athanasou NA 1994 Dexamethasone stimulates osteoclast-like cell formation by inhibiting granulocyte-macrophage colony-stimulating factor production in mouse bone marrow cultures. Endocrinology 134:1121-1126
35. Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, Taniguchi T 2000 T-cellmediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature 408:600-605
36. Kasono K, Sato K, Sato Y, Tsushima T, Shizume K, Demura H 1993 Inhibitory effect of interleukin-4 on osteoclast-like cell formation in mouse bone marrow culture. Bone Miner 21:179-188
37. Lacey DL, Erdmann JM, Teitelbaum SL, Tan HL, Ohara J, Shioi A 1995 Interleukin 4, interferon-γ, and prostaglandin E impact the osteoclastic cellforming potential of murine bone marrow macrophages. Endocrinology 136:2367-2376
38. Bendixen AC, Shevde NK, Dienger KM, Willson TM, Funk CD, Pike JW 2001 IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor γ1. Proc Natl Acad Sci USA 98:2443-2448
39. Salvi GE, Lang NP 2005 The effects of non-steroidal anti-inflammatory drugs (selective and non-selective) on the treatment of periodontal diseases. Curr Pharm Des 11:1757-1769
40. Head JE, Bryant BJ, Grills BL, Ebeling PR 2001 Effects of short-term use of ibuprofen or acetaminophen on bone resorption in healthy men: a doubleblind, placebo-controlled pilot study. Bone 29:437-441